NASDAQ BMRN opened at $57.68 on Friday. BioMarin Pharmaceutical Inc. has a 1-year low of $52.93 and a 1-year high of $93.04. The company has a current ratio of 5.56, a quick ratio of 3.60 and a debt-to-equity ratio of 0.10. The company has a market capitalization of $11.08 billion, a PE ratio of 17.12, a price-to-earnings-growth ratio of 0.75 and a beta of 0.18. The firm's fifty day simple moving average is $57.70 and its 200-day simple moving average is $61.23.